News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alizyme PLC  (AZM.L) Successful Phase IIb Cetilistat Trial In Obese Diabetics


12/13/2005 3:06:43 PM

Alizyme plc (LSE:AZM) is pleased to announce the preliminary results of its successful Phase IIb clinical trial of cetilistat in clinically obese diabetic patients.


comments powered by Disqus
   
Obesity
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES